Back of the envelope calculation...
Over 300-350 million shares traded hands at close to or more than $3. Owner(s) of these shares will definitely vote NO to Albermarle's $3 offer. That equates to around 7% of outstanding 2.2 billion shares.
Diehard retail lionnaires will vote NO as well.
I guess another 300-350 million shares traded above $3 in the coming weeks (days?) will be the nail in the coffin of Albermarle's bid.
GLTAH
- Forums
- ASX - By Stock
- Ann: Revised Proposal from Albemarle
Back of the envelope calculation...Over 300-350 million shares...
Featured News
Add LTR (ASX) to my watchlist
(20min delay)
|
|||||
Last
87.5¢ |
Change
0.035(4.17%) |
Mkt cap ! $2.121B |
Open | High | Low | Value | Volume |
85.0¢ | 89.5¢ | 84.5¢ | $14.42M | 16.61M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 112120 | 87.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
87.5¢ | 79469 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 112120 | 0.870 |
4 | 93230 | 0.865 |
5 | 77327 | 0.860 |
4 | 161823 | 0.855 |
10 | 425000 | 0.850 |
Price($) | Vol. | No. |
---|---|---|
0.875 | 79469 | 3 |
0.880 | 20475 | 3 |
0.885 | 7190 | 2 |
0.890 | 340248 | 14 |
0.895 | 160337 | 15 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online